Effect of 1,25(OH)2D3 on rat peritoneal mesothelial cells treated with high glucose plus lipopolysaccharide

Cellular Immunology

Volumn 271, Issue 1, 2011, Pages 173-179

  Yang, Lina ^a   Wang, Jun ^a   Fan, Yi ^a   Chen, Shuo ^a   Wang, Lining ^a   Ma, Jianfei ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

1,25(OH)2D3; High glucose; Lipopolysaccharide; Rat peritoneal mesothelial cells; VDR

Indexed keywords

CALCIFEDIOL; GLUCOSE; LIPOPOLYSACCHARIDE; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL STIMULATION; CELL VIABILITY; CONCENTRATION (PARAMETERS); CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; FIBROSIS; MESOTHELIUM CELL; NONHUMAN; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION;

ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CALCITRIOL; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; GLUCOSE; LIPOPOLYSACCHARIDES; PERITONEAL CAVITY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CALCITRIOL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VITAMINS;

NEGIBACTERIA; RATTUS;

EID: 80052391022     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.06.017     Document Type: Article

References (39)

1. Ha H., Lee H.B. Effect of high glucose on peritoneal mesothelial cell biology. Perit. Dial. Int. 2000, 20(Suppl. 2):S15-S18.
2. Margetts P.J., Bonniaud P. Basic mechanisms and clinical implications of peritoneal fibrosis. Perit. Dial. Int. 2003, 23:530-541.
3. Liu A.C., Gotlieb A.I. Transforming growth factor-beta regulates in vitro heart valve repair by activated valve interstitial cells. Am. J. Pathol. 2008, 173:1275-1285.
4. Zimmerman C.M., Padgett R.W. Transforming growth factor beta signaling mediators and modulators. Gene 2000, 249:17-30.
5. Tsunawaki S., Sporn M., Ding A., Nathan C. Deactivation of macrophages by transforming growth factor-beta. Nature 1998, 334:260-262.
6. Smith W.B., Noack L., Khew-Goodall Y., Isenmann S., Vadas M.A., Gamble J.R. Transforming growth factor-beta 1 inhibits the production of IL-8 and the transmigration of neutrophils through activated endothelium. J. Immunol. 1996, 157:360-368.
7. Branton M.H., Kopp J.B. TGF-beta and fibrosis. Microb. Infect. 1999, 1:1349.
8. Wang H., Radjendirane V., Wary K.K., Chakrabarty S. Transforming growth factor beta regulates cell-cell adhesion through extracellular matrix remodeling and activation of focal adhesion kinase in human colon carcinoma Moser cells. Oncogene 2004, 23:5558-5561.
9. Attisano L., Silvestri C., Izzi L., Labbé E. The transcriptional role of Smads and FAST (FoxH1) in TGFbeta and activin signalling. Mol. Cell. Endocrinol. 2001, 180:3-11.
10. Wrana J.L. Regulation of Smad activity. Cell 2000, 100:189-192.
11. Massague J., Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 2000, 19:1745-1754.
12. Hua X.X., Miller Z.A., Wu G., Shi Y.G., Lodish H.F. Specificity in transforming growth factor beta-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and Smad proteins. Proc. Natl. Acad. Sci. USA 1999, 96:13130-13135.
13. Thapa D., Lee J.S., Park M.A., Cho M.Y., Park Y.J., Choi H.G., et al. Inhibitory effects of clotrimazole on TNF-alpha-induced adhesion molecule expression and angiogenesis. Arch. Pharm. Res. 2009, 32:593-603.
14. Aoudjit F., Brochu N., Belanger B., Stratowa C., Hiscott J., Audette M. Regulation of intercellular adhesion molecule-1 gene by tumor necrosis factor alpha is mediated by the nuclear factor-kappaB heterodimers p65/p65 and p65/c-Rel in the absence of p50. Cell Growth Differ. 1997, 8:335-342.
15. Thompson P.D., Hsieh J.C., Whitfield G.K., Haussler C.A., Jurutka P.W., Galligan M.A., et al. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor. J. Cell. Biochem. 1999, 75:462-480.
16. Calle C., Maestro B., García-Arencibia M. Genomic actions of 1,25-dihydroxyvitamin D3 on insulin receptor gene expression, insulin receptor number and insulin activity in the kidney, liver and adipose tissue of streptozotocin-induced diabetic rats. BMC Mol. Biol. 2008, 9:65.
17. González-Sancho J.M., Larriba M.J., Ordóñez-Morán P., Pálmer H.G., Muñoz A. Effects of 1alpha,25-dihydroxyvitamin D3 in human colon cancer cells. Anticancer Res. 2006, 26(4A):2669-2681.
18. Anderson P., May B., Morris H. Vitamin D metabolism: new concepts and clinical implications. Clin. Biochem. Rev. 2003, 24:13-26.
19. Gocek E., Kiełbiński M., Wyłób P., Kutner A., Marcinkowska E. Side-chain modified vitamin D analogs induce rapid accumulation of VDR in the cell nuclei proportionately to their differentiation-inducing potential. Steroids 2008, 73:1359-1366.
20. Tan X., Li Y., Liu Y. Therapeutic role and potential mechanisms of active Vitamin D in renal interstitial fibrosis. J. Steroid Biochem. Mol. Biol. 2007, 103:491-496.
21. Hjelle J.T., Golinska B.T., Waters D.C., Steidley K.R., McCarroll D.R., Dobbie J.W. Isolation and propagation in vitro of peritoneal mesothelial cells. Perit. Dial. Int. 1989, 9(4):341-347.
22. Li Z.M., Ma J.F., Wang L.N. Lipopolysaccaride influenced peritoneal mesothelial cells on the growth and expression of tumor necrosis factor through nuclear factor kappaB pathway. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2007, 23:346-349.
23. Davies S.J., Phillips L., Griffiths A.M., Russell L.H., Naish P.F., Russell G.I. What really happens to people on long-term peritoneal dialysis?. Kidney Int. 1998, 54:2207-2217.
24. Churchill D.N., Thorpe K.E., Nolph K.D., Keshaviah P.R., Oreopoulos D.G., Page D. Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients. J. Am. Soc. Nephrol. 1998, 9:1285-1292.
25. Williams J.D., Craig K.J., von Ruhland C., Topley N., Williams G.T. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int. Suppl. 2003, 88:S43-S49. on behalf of the Biopsy Registry Study Group.
26. Shany S., Levy R., Chaimovitz C. Effect of 1,25-dihydroxyvitamin D on the immune activity of peritoneal macrophages in continuous ambulatory peritoneal dialysis patients. Nephron 1995, 69:367-370.
27. Rigby W.F. The immunobiology of vitamin D. Immunol. Today 1988, 9:54-58.
28. Mizuiri S., Ohashi Y., Hemmi H., Arita M., Yamada K., Aoki T., et al. Effects of new peritoneal dialysis solutions, pyridoxamine and AT1 receptorblocker, on TGF-beta1 and VEGF expression in rat peritoneal mesothelial cells. Am. J. Nephrol. 2009, 16(30):295-302.
29. Takazoe K., Nakayama M., Utsunomiya Y., Osaka N., Hayakawa H., Kubo H., et al. Detection of TGF-beta1 in CAPD effluents. Clin. Nephrol. 1997, 47:67-69.
30. Kang D.H., Hong Y.S., Lim H.J., Choi J.H., Han D.S., Yoon K.I. High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation. Perit. Dial. Int. 1999, 19:221-230.
31. Ha H., Yu M.R., Lee H.B. High glucose-induced PKC activation mediates TGF-b1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int. 2001, 59:463-470.
32. Wong T.Y., Phillips A.O., Witowski J., Topley N. Glucose-mediated induction of TGF-b1 and MCP-1 in mesothelial cells in vitro is osmolality and polyol pathway dependent. Kidney Int. 2003, 63:1404-1416.
33. Subramaniam N., Leong G.M., Cock T.A., Flanagan J.L., Fong C., Eisman J.A., et al. Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements. J. Biol. Chem. 2001, 276:15741-15746.
34. Yanagi Y., Suzawa M., Kawabata M., Miyazono K., Yanagisawa J., Kato S. Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J. Biol. Chem. 1999, 274:12971-12974.
35. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., et al. Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 1999, 283:1317-1321.
36. Alroy A., Towers T.L., Freedman L.P. Transcriptional repression of the interleikin-2 gene by vitamin D3: direct inhibition of NFAT/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 1995, 15:5789-5799.
37. Aschenbrenner J.K., Sollinger H.W., Becker B.N., Hullett D.A. 1,25-(OH2)D3 alters the transforming growth factor beta signaling pathway in renal tissue. J. Surg. Res. 2001, 100:171-175.
38. Akashi S., Shimazu R., Ogata H., Nagai Y., Takeda K., Kimoto M., et al. Cutting edge: cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 2000, 164:3471-3475.
39. Takeda K., Akira S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17:1-14.